A new “wonder drug” injection for uncontrolled asthma has been approved for use on the NHS. The National Institute for Health and Care Excellence (Nice) has recommended dupilumab for some
Read More
Campaigners are urging a health watchdog to publish a new guideline on diagnosing and managing ME, warning that each day of delay “puts more people at risk”. The National Institute
Read More
Thousands of lives could be saved by a new heart disease drug that health officials hope will become widely available on the NHS as early as next year. Patients will
Read More
The number of NHS mental health patients being sent to care facilities away from their local area should be reduced, new draft guidelines have recommended. The National Institute for Health
Read More
Two cannabis-based medicines have been recommended for use on the NHS for the first time. Epidyolex has been approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while
Read More
A “long hoped-for” deal has been reached to provide lifesaving cystic fibrosis drugs on the NHS which could help thousands of sufferers. Around 5,000 NHS patients will now have full
Read More
The first targeted immunotherapy treatment for people with triple negative breast cancer has been provisionally rejected for use on the NHS. The National Institute for Health and Care Excellence (Nice)
Read More
European regulators have, for the first time, approved a drug containing cannabis for rare, but severe, forms of childhood epilepsy. The drug Epidyolex is now available for use in the
Read More
The UK’s medical advisory body has refused to recommend a cannabis-based drug on the NHS to treat two severe forms of childhood epilepsy. The National Institute for Health and Care
Read More
Campaigners have welcomed a “forward-thinking and positive” NHS England review into the use of medical cannabis to treat illnesses like severe epilepsy. The report found “major hurdles” in prescribing cannabis-based
Read More